Selection bias occurs when the available records or included patients do not represent the study population investigators intend to examine. Confounding arises when another variable is related to both an exposure or intervention and an outcome, making relationships harder to interpret. Distinguishing these problems helps researchers avoid treating an observed association as a definitive effect.
Missing clinical, pathological, treatment, or survival information can reduce the completeness of comparisons and may make some patients appear less documented than others. Differences in follow-up also mean that outcomes are not observed for equivalent periods. These limitations can influence apparent patterns, so conclusions should reflect the quality and timing of the available data.
Because investigators do not assign treatments prospectively, treatment groups may differ in patient characteristics or clinical circumstances before outcomes are compared. Retrospective Analysis can therefore reveal associations in real-world records, but the findings require careful consideration of confounding and selection bias. This limitation is especially important when evaluating whether an intervention relates to improved outcomes.
A study begins by defining the population and the research question. Investigators identify relevant existing records or databases, then extract clinical, pathological, treatment, and survival information. They next examine relationships among exposures, interventions, and outcomes. Clear population boundaries and consistent variable extraction help make comparisons more interpretable within the available cancer data.
Its applications include examining treatment effectiveness, identifying prognostic factors, describing disease progression, and comparing patient characteristics. Because the information comes from clinical records and databases, investigators can study how these features relate to outcomes in real-world settings. The resulting evidence may clarify patterns worth testing further, while remaining subject to the study's data limitations.
It can provide efficient access to accumulated clinical experience and reveal associations across patient groups, treatments, and outcomes without waiting for new follow-up to occur. This makes it valuable for evaluating real-world patterns and generating hypotheses. Its contribution is strongest when researchers interpret findings alongside incomplete records, selection bias, confounding, and unequal follow-up.